Trial Profile
Phase I Alimta Combination With BMS-275183 (Oral Taxane)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Mar 2010
Price :
$35
*
At a glance
- Drugs BMS 275183 (Primary) ; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 22 May 2009 New trial record.